FDA authorizes new rapid COVID-19 test, says capacity will double
October 4, 2021 - The Food and Drug Administration (FDA) on Monday authorized a new rapid, at-home COVID-19 test, in a move it said is expected to double the availability of such tests in the coming weeks. The FDA said it has authorized a coronavirus test from the company ACON Laboratories. It is not the first authorization of such a test, which can deliver results in as little as 15 minutes, but, amid supply shortages, the move could be key in boosting their availability. Jeff Shuren, a top FDA official, said the move "is expected to double rapid at-home testing capacity in the U.S. over the next several weeks. Read the full article here.